Skip to main content
. Author manuscript; available in PMC: 2018 Feb 9.
Published in final edited form as: Clin Gastroenterol Hepatol. 2008 Dec 27;7(4):487–493. doi: 10.1016/j.cgh.2008.12.018

Table 3.

Clinical characteristics of patients in clinical trials assessing the efficacy of primary antibiotic prophylaxis in patients with low total protein in the ascitic fluid.

Author Cause of Cirrhosis Rx Group Cause of Cirrhosis Placebo Group MELD Score* Rx Group MELD Score* Placebo Group Child Pugh Score** Rx Group Child Pugh Score** Placebo Group
Terg23 N/A N/A NA NA 8.5±1.5 8.3±1.3
Novella22 Alcohol 31, Hep C 22, Other 3 Alcohol 31, Hep C 19, Hep B 3 NA NA CP class B/C 29/27 CP class B/C 24/29
Grange21 Alcohol 48, Viral 4, Other 1 Alcohol 45, Viral 6, Other 3 NA NA NA NA
Fernandez20 Alcohol 20, Other 15 Alcohol 16, Other 17 16.7±3.0 10.4±1.5 9.9±1.5 10.4±1.5

Abbreviations: Rx, treatment;

*

MELD, model for end stage liver disease (range: 6–40)

**

Child Pugh Score (range: 0–15)